A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2006
11/02/2006	EP1717251A2 Methods of therapy for B-cell malignancies using human anti-CD40 antibodies
11/02/2006	EP1717229A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1716861A2 Inhibitors of proteasomal activity for stimulating bone and hair growth
11/02/2006	EP1716856A2 The treatment of acne
11/02/2006	EP1716855A1 Remedy for external use for skin and mucosal injuries caused by viral infection
11/02/2006	EP1716854A1 External preparation for treating painful skin wound
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716110A1 Androgen receptor modulators
11/02/2006	EP1715892A2 Methods and compositions for modulating angiogenesis
11/02/2006	EP1715881A1 Cysteine rich peptides for improving thiol homeostasis
11/02/2006	EP1715869A1 Method of stimulating hair growth
11/02/2006	EP1715866A2 Protease inhibitors for treatment of wrinkles
11/02/2006	EP1715785A2 Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
11/02/2006	EP1660068A4 Composition for treatment of tinea pedis and method of use
11/02/2006	EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006	EP1446394B1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1349537B1 Skin care product containing retinoids and phytoestrogens in a dual compartment package
11/02/2006	EP1296923B1 Aspirin-triggered lipid mediators
11/02/2006	EP1276760B1 Polyamide nucleic acid derivatives, agents and methods for producing them
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1180035B1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1-alpha, 25-DIHYDROXY VITAMIN D3
11/02/2006	EP1107768B1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0813405B1 Polypodium extract as photoprotectant
11/02/2006	EP0769961B1 Use of bacterial enzymes e.g. heparinases, chondroitinases for modulating wound healing processes
11/02/2006	EP0719331B1 Eotaxin = eosinophil chemotactic cytokine
11/02/2006	CA2606392A1 Hair tonic
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2605383A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	CA2605365A1 Remedy for xanthoma
11/02/2006	CA2604856A1 Dermal fillers for biomedical applications in mammals and methods of using the same
11/01/2006	CN1856709A Method of predicting spot formation on the skin with the use of spot site-accelerating genes as indication and method of screening inhibitor for spot formation on the skin
11/01/2006	CN1856318A Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
11/01/2006	CN1856293A Anhydrous topical formulation for polyphenols
11/01/2006	CN1853730A Modified cytokines for use in cancer therapy
11/01/2006	CN1853727A Polysaccharide-containing compositions and use thereof
11/01/2006	CN1853703A Obtundent healing paste for treating burn and scald
11/01/2006	CN1853699A Chinese medicine for treating burn and scald
11/01/2006	CN1853695A Chinese medicine for treating leucoderma and preparation thereof
11/01/2006	CN1853690A Chinese medicinal prescription for treating osmidrosis
11/01/2006	CN1853662A Pearl cosmetic tablets
11/01/2006	CN1853661A Pearl cosmetic composition
11/01/2006	CN1853649A Preparation of externally-applied verruga, clavus and beriberi
11/01/2006	CN1853613A Crease-proofing biological preparation, its production and use
11/01/2006	CN1853612A Externally-applied preparation containing oily substance extracted from glossy ganoderma for skin and use thereof
11/01/2006	CN1853609A Skin-care effectiveness applied by acid fiber mother cell growth factor (FGF-1)
11/01/2006	CN1853608A Cosmetic/dermatological compositions
11/01/2006	CN1282649C Corter pseudolaricis acid derivatives, preparation method and use thereof
11/01/2006	CN1282640C N-arylphenylacetamide derivatives and medicinal compositions containing same
11/01/2006	CN1282636C Vitamin D analogues
11/01/2006	CN1282482C Chinese medicine liniment for treating acne and its preparation method
11/01/2006	CN1282472C Anthemonhagic medicament for quick blood coagulation and diminish inflammation
11/01/2006	CN1282471C Medicine for treating anaphylactic dermatosis
11/01/2006	CN1282455C Radiation resistant medicament of ginko flavone and tea polyphenol
11/01/2006	CN1282454C Oral composition for hydrating mammal skin and kit and method thereof
10/2006
10/31/2006	US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006	US7129365 Solvent extraction using free radical scavenger; isolation
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129275 Compositions for treating acne comprising phytandiol amine
10/31/2006	US7129270 Antiinflammatory agents
10/31/2006	US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006	US7129253 Compounds
10/31/2006	US7129251 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
10/31/2006	US7129246 N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation
10/31/2006	US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129241 Pyridazine derivatives
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006	US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss
10/31/2006	US7129219 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group
10/31/2006	US7128900 Light-protection agents
10/31/2006	CA2355886C Substituted oximes and hydrazones as neurokinin antagonists
10/31/2006	CA2329217C Stable extended release oral dosage composition comprising desloratadine and pseudoephedrine
10/31/2006	CA2302850C Stretch mask with an adhesive matrix that can be extended at least when wet
10/31/2006	CA2276455C Phthalazinones
10/31/2006	CA2142811C Novel glucan preparation
10/26/2006	WO2006113331A1 Methods for treating and preventing fibrosis by il-21 / il-21r antagonists
10/26/2006	WO2006112619A1 Compositions for treating alopecia or promoting hair growth
10/26/2006	WO2006112012A1 Nutrient composition
10/26/2006	WO2006111783A1 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents
10/26/2006	WO2006111633A2 Use of lecithin as a medicament for treating psoriasis
10/26/2006	WO2006111542A1 Method for increasing the speed of recovery and/or the speed of wound healing of injured animals
10/26/2006	WO2006111426A1 Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
10/26/2006	WO2006111092A1 Preparation and application of heparin silver
10/26/2006	WO2006079568A3 Use of 3-sulfanylpropanamide derivatives for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof
10/26/2006	WO2005113534A3 Cxcr1 and cxcr2 chemokine antagonists
10/26/2006	WO2002100445A8 Treatment and composition for wound healing
10/26/2006	US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof
10/26/2006	US20060241179 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
10/26/2006	US20060241171 Novel physiologically active substances
10/26/2006	US20060241132 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/26/2006	US20060241131 Pyrrolo[2,3-d]pyrimidine compounds
10/26/2006	US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation
10/26/2006	US20060241116 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates
10/26/2006	US20060241112 Kinase inhibitors
10/26/2006	US20060241049 below the kneecap in a diabetic subject; administering agonist of the non-proteolytically activated thrombin receptor
10/26/2006	US20060240123 Pharmaceutical composition

1 ... 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 ... 1065